ID
28041
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: LpPLA2 Activity
Keywords
Versions (3)
- 8/27/17 8/27/17 -
- 10/23/17 10/23/17 -
- 12/12/17 12/12/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
December 12, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
LpPLA2 Activity GSK study Chronic Coronary Heart Disease NCT00799903
LpPLA2 Activity GSK study Chronic Coronary Heart Disease NCT00799903
Description
LpPLA2 Activity
Description
Date and time sample taken
Data type
text
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0200345
Description
Date sample taken
Data type
date
Alias
- UMLS CUI [1]
- C1302413
Description
Time sample taken
Data type
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0200345
Similar models
LpPLA2 Activity GSK study Chronic Coronary Heart Disease NCT00799903
C1556095 (UMLS CUI [2])
C0152035 (UMLS CUI [3])
C0200345 (UMLS CUI [1,2])
C0200345 (UMLS CUI [1,2])